In vitro growth changes of oral human keratinocytes after treatment with carotenoids, retinoid, and/or DMBA

Nutrition and Cancer

Volumn 33, Issue 1, 1999, Pages 58-68

  Schwartz, Joel L ^a  

^a HOWARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CANTHAXANTHIN; CAROTENOID; DIMETHYLBENZ[A]ANTHRACENE; GAMMA GLUTAMYLTRANSFERASE; KERATIN; PROTEIN P53; RETINOID; RETINOL PALMITATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; OXIDATION; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN TUMOR;

EID: 0032967575     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589909514749     Document Type: Article

References (51)

1. Schwartz, JL: Nutrition and chemoprevention of head, neck, and lung cancers. In Nutritional Oncology, D Heber, GL Blackburn, and VLW Go (eds). New York: Academic, 1998, chapt 28.
2. Shklar, G, and Schwartz, JL: Oral cancer inhibition by micronutrients. The experimental basis for clinical trials. Eur J Cancer B Oral Oncol 29, 9-13, 1993.
3. Suda, D, Schwartz, JL, and Shklar, G: GOT reduction in β-carotene inhibition of hamster buccal pouch carcinogenesis. Eur J Cancer Clin Oncol 23, 43-46, 1987.
4. Shklar, G, and Schwartz, JL: Vitamin E, the expression of p53, and the suppression of neovascularization. Eur J Cancer B Oral Oncol 32, 114-119, 1996.
5. Schwartz, JL, and Shklar, G: The expression of p53 and the inhibition of neovascularization and oral carcinogenesis with glutathione treatment. Nutr Cancer 26, 229-237, 1996.
6. Garewal, HS: Emerging role of β-carotene and other antioxidant nutrients in prevention of oral cancer. Arch Otolaryngol Head Neck Surg 121, 141-144, 1995.
7. Lippman, SM, Heyman, RA, Kurie, JM, Benner, SE, and Hong, WK: Retinoids and chemoprevention. Clinical and basic studies. J Clin Oncol 22 Suppl, 851-873, 1995.
8. Park, NH, Gujuluva, CN, Baek, JH, Cherrick, HM, Shin, KH, et al.: Combined oral carcinogenicity of HPV-16 and benz[a]pyrene: an in vitro multistep carcinogenesis model. Oncogene 10, 2145-2153, 1995.
9. Liu, X, Han, S, Baluda, MA, and Park, NH: HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 14, 2347-2353, 1997.
10. Sugarman, PB, and Shillitoe, EJ: The high-risk human papilloma viruses and oral cancer: evidence for and against a causal relationship. Oral Dis 3, 130-147, 1997.
11. Tomakidi, P, Fusenig, NE, Kohl, A, and Komposch, G: Histomorphological and biochemical differentiation capacity in organotypic co-cultures of primary gingival cells. J Periodontol Res 32, 388-400, 1997.
12. Chung, JH, Cho, KH, Lee, DY, Kwon, OS, Sung, MW, et al.: Human oral buccal mucosa reconstructed on dermal substrates: a model for oral epithelial differentiation. Arch Dermatol Res 289, 677-685, 1997.
13. Reid, CB, Cloos, J, Snow, GB, and Braakhaus, BJ: A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts. Acta Otolaryngol (Stockh) 117, 628-633, 1997.
14. Fahey, MS, Paterson, IC, Stone, A, Collier, AJ, Heug, YL, et al.: Dysregulation of autocrine TGF-β isoform production and malignant responses in human tumour-derived and Ha-ras transfected keratino-cytes and fibroblasts. Br J Cancer 74, 1074-1080, 1996.
15. 1 on growth regulatory genes in tumour derived human oral keratinocytes. Br J Cancer 72, 922-927, 1995.
16. Drugan, CS, Stone, A, Game, BM, and Prime, SS: The mitogenic effect of KGF and the expression of its cell surface receptor on cultured normal and malignant human oral keratinocytes and on continuous fibroblasts. J Oral Pathol Med 26, 327-333, 1997.
17. Kapas, S, Brown, DW, Farthing, PM, and Hagi-Pavli, E: Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett 418, 287-290, 1997.
18. 1 transition via a p53-independent pathway in human epithelial cells. Oncogene 15, 1143-1149, 1997.
19. 2 and interleukin-1 concentrations in nicotine-exposed oral keratinocyte cultures. J Periodontal Res 32, 447-454, 1997.
20. Rubinstein, T, Gao, XP, Pakhlevaniants, S, and Oda, D: Smokeless tobacco-exposed oral keratinocytes increase macromolecular efflux from the in situ oral mucosa. Am J Physiol 274, R104-R111, 1998.
21. 2 and interleukin-1. J Periodontol 67, 116-124, 1996.
22. Maruoka, Y, Harada, H, Mitsuyasu, T, Seta, Y, Kurokawa, H, et al.: Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 238, 886-890, 1997.
23. Harada, H, Mitsuyasu, T, Seta, Y, Maruoka, U, Toyoshima, K, et al.: Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J Oral Pathol Med 27, 11-17, 1998.
24. Kang, MK, Guo, W, and Park, NH: Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Differ 9, 85-95, 1998.
25. Schwartz, JL, and Shklar, G: Verification in syngeneic hamsters of in vitro transformation of hamster oral mucosa by 7,12 dimethylbenz[a]anthracene. Eur J Cancer B Oral Oncol 33, 431-438, 1997.
26. Rutenberg, AA, Kim, H, Fishbein, J, Harper, J, Wasserkurg, H, et al.: Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 17, 517-528, 1969.
27. Solt, DB: Localization of γ-glutamyl transpeptidase in hamster buccal pouch epithelium treated with 7,12 dimethylbenz[a]anthracene. JNCI 67, 193-200, 1981.
28. Calderon-Solt, L, and Solt, DB: γ-Glutamyl transpeptidase in pre-cancerous lesions and carcinomas of oral, laryngeal, and laryngeal mucosa. Cancer 56, 138-143, 1985.
29. Rheinwald, JG, and Beckett, MP: Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22, 629-632, 1980.
30. Sun, TT, and Green, H: Differentiation of the epidermal keratinocytes in cell culture: formation of the cornified envelope. Cell 9, 511-521, 1976.
31. 32 P-postlabelling analysis of human placental DNA known to contain benz[a]pyrene, diol epoxides adducts. Carcinogenesis 11, 553-559, 1990.
32. Schwartz, JL, Hynn, D, Trickier, D, and Shklar, D: Directed lysis of experimental cancer by β-carotene in liposomes. Nutr Cancer 16, 107-124, 1991.
33. Schwartz, JL, Singh, RP, Teicher, B, Wright, JG, Trites, DH, et al.: The induction of a 70 kD protein associated with the selective cytotoxic activity of β-carotene in human epidermal carcinoma. Biochem Biophys Res Commun 169, 941-946, 1990.
34. Schwartz, JL: In vitro biological methods for determinations of carotenoid activity. Methods Enzymol 214, 226-256, 1993.
35. Schwartz, JL, and Shklar, G: The selective cytotoxic effect of carotenoids and a tocopherol on human cancer cell lines in vitro. J Oral Maxillofac Surg 50, 357-373, 1992.
36. Schwartz, JL, Shklar, G, and West, K: Altered cytokeratin expression in carcinogenesis inhibition by antioxidant nutrients. Nutr Cancer 24, 47-56, 1995.
37. Boyl, JO, Hakim, J, Kosh, W, van der Riet, P, Hruban, RH, et al.: The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53, 4477-4480, 1993.
38. Heinzel, PA, Balaram, P, and Bernard, H: Mutations and polymorphisms in the p53, pp21, and p16 genes in oral carcinoma of Indian betel quid chewers. Int J Cancer 68, 420-423, 1996.
39. Pavelic, ZP, Li, YQ, Stambrook, PJ, McDonald, JS, Munck-Wikland, E, et al.: Overexpression of p53 protein is common in premalignant head and neck lesions. Anticancer Res 14, 2259-2266, 1994.
40. Ming, L, Pelling, JC, Ju, J, Chu, E, and Brash, DE: Antioxidant action via p53-mediated apoptosis. Cancer Res 58, 1723-1729, 1998.
41. Freshney, RI: Transformation. In Culture of Epithelial Cells, RI Freshney (ed). New York: Wiley-Liss, 1992, pp 1-23.
42. Evan, G, and Littlewood, T: A matter of life and cell death. Science 281, 1317-1322, 1998.
43. Schwartz, JL, Tanaka, J, Khanadekar, V, Herman, TS, and Teicher, BA: β-Carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemother Pharmacol 29, 207-213, 1992.
44. Burton, GW, and Ingold, KU: β-Carotene, an unsual type of lipid antioxidant. Science 224, 509-513, 1989.
45. Green, DR, and Reed, JC: Mitochondria and apoptosis. Science 281, 1309-1312, 1998.
46. Boyce, ST, and Ham, RG: Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial cultures. J Invest Dermatol 81, 33-40, 1983.
47. An, WG, Kanekal, M, Simon, C, Maltepe, E, Blagosklonny, MV, et al.: Stablization of wild type p53 by hypoxia inducible factor 1α. Nature 392, 405-408, 1998.
48. Hainaut, P, and Milner, J: Redox modulation of p53 conformation and sequence specific DNA binding in vitro. Cancer Res 53, 4469-4473, 1993.
49. Kane, DJ, Sarafian, TA, Anton, R, Hahn, H, Gralla, ED, et al.: Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277, 1993.
50. Shimizu, S, Eguchi, Y, Kosaka, H, Kamilke, W, Matsuda, H, et al.: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-x1. Nature 374, 811-813, 1995.
51. Adams, JM, and Cory, S: The Bcl-2 protein family, arbiters of cell survival. Science 281, 1322-1325, 1998.